Original Research

Published on 09 Aug 2022

The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes

in Allergen Immunotherapy

Marguerite Thétis-Soulié
Maxime Hosotte
Isabelle Grozelier
Claire Baillez
Silvia Scurati
Valérie Mercier

Frontiers in Allergy

doi 10.3389/falgy.2022.971155

3,129 views
8 citations

Review

Published on 03 Aug 2022

Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy

in Allergen Immunotherapy

Masaya Matsuda
Tetsuya Terada
Kazuyuki Kitatani
Ryo Kawata
Takeshi Nabe

Frontiers in Allergy

doi 10.3389/falgy.2022.981126

3,836 views
13 citations

Mini Review

Published on 12 Jul 2022

Measuring the Impact of Food Immunotherapy on Health-Related Quality of Life in Clinical Trials

in Allergen Immunotherapy

Melanie Lloyd
Audrey Dunn Galvin
Mimi L. K. Tang

Frontiers in Allergy

doi 10.3389/falgy.2022.941020

4,154 views
8 citations

Review

Published on 28 Jun 2022

Patient's Adherence and Compliance and Quality of Life During/After VIT

in Allergen Immunotherapy

Cristoforo Incorvaia
Enrico Heffler
Silvia Peveri
Francesco Pucciarini
Giorgio Walter Canonica
Erminia Ridolo

Frontiers in Allergy

doi 10.3389/falgy.2022.886054

3,837 views
1 citation

Mini Review

Published on 16 Jun 2022

Mast Cell Desensitization in Allergen Immunotherapy

in Allergen Immunotherapy

Celia López-Sanz
Rodrigo Jiménez-Saiz
Vanesa Esteban
María Isabel Delgado-Dolset
Carolina Perales-Chorda
Alma Villaseñor
Domingo Barber
María M. Escribese

Frontiers in Allergy

doi 10.3389/falgy.2022.898494

8,586 views
6 citations

Clinical Trial

Published on 16 Mar 2022

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans

in Allergen Immunotherapy

Alexandra Chabot
Gabriela Senti
Iris Erdmann
Bettina M. Prinz
Brunello Wüthrich
Lara Šošić
Thomas M. Kündig
Pål Johansen

Frontiers in Allergy

doi 10.3389/falgy.2022.832010

4,095 views
7 citations

Original Research

Published on 05 Jan 2022

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients

in Allergen Immunotherapy

Huan Chen
Guo-qing Gong
Mei Ding
Xiang Dong
Yuan-li Sun
Lang Wan
Ya-dong Gao

Frontiers in Allergy

doi 10.3389/falgy.2021.810133

4,016 views
4 citations

Brief Research Report

Published on 16 Dec 2021

Specific Immunotherapy in a Murine Model of Grass Pollen (Phl p5b)-Induced Airway Inflammation

in Allergen Immunotherapy

Matthias Stiehm
Marcus Peters

Frontiers in Allergy

doi 10.3389/falgy.2021.777545

1,892 views
2 citations

Specialty Grand Challenge

Published on 05 Aug 2021

Grand Challenges in Allergen Immunotherapy

in Allergen Immunotherapy

Linda Cox

Frontiers in Allergy

doi 10.3389/falgy.2021.710345

2,922 views
2 citations

Navigation group

Articles

The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes

Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy

Measuring the Impact of Food Immunotherapy on Health-Related Quality of Life in Clinical Trials

Patient's Adherence and Compliance and Quality of Life During/After VIT

Mast Cell Desensitization in Allergen Immunotherapy

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients

Specific Immunotherapy in a Murine Model of Grass Pollen (Phl p5b)-Induced Airway Inflammation

Grand Challenges in Allergen Immunotherapy